Standout Papers

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer 2023 2026 202499
  1. Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer (2023)
    Stephen J. Freedland, Murilo Luz et al. New England Journal of Medicine

Immediate Impact

39 standout
Sub-graph 1 of 18

Citing Papers

Evolution of Hybrid Hydrogels: Next-Generation Biomaterials for Drug Delivery and Tissue Engineering
2024 Standout
Dendritic Cells in Cancer Immunology and Immunotherapy
2024 Standout
2 intermediate papers

Works of Christopher Pieczonka being referenced

Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data
2017
The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.
2014

Author Peers

Author Last Decade Papers Cites
Christopher Pieczonka 392 126 103 137 69 627
Takashi Fukagai 470 185 98 134 66 713
Kenta Miki 444 79 88 105 69 637
Oliver W. Hakenberg 496 132 166 194 56 702
A. De La Taille 519 93 59 136 56 704
J.M. Abascal Junquera 488 245 83 196 72 732
A. De La Taille 488 57 73 101 53 567
Lorenzo Tosco 611 109 73 139 41 731
Keita Tamura 403 185 77 177 68 619
P. Cathcart 233 229 44 163 34 600
Charles Van Praet 394 85 95 237 72 721

All Works

Loading papers...

Rankless by CCL
2026